<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000774804">
  <TermName>COPDAC</TermName>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination that is often used with radiation therapy to treat certain types of childhood Hodgkin lymphoma in males. It includes the drugs cyclophosphamide, vincristine sulfate (Oncovin), prednisone, and dacarbazine. Also called COPDAC regimen.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>COPDAC</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que a menudo se usa con radioterapia para el tratamiento de ciertos tipos de linfoma de Hodgkin infantil en varones. Incluye los medicamentos ciclofosfamida, sulfato de vincristina (Oncovin), prednisona y dacarbazina. También se llama régimen COPDAC.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2015-09-11</DateFirstPublished>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000775347" url="/about-cancer/treatment/drugs/COPDAC">COPDAC</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
